×

Your Questions About... Banks, Amgen

graphic_fast_money.jpg

Time to sort through the Fast Money in-box and answer more of your questions.

Thomas from Michigan

Thomas writes, "Is it time to short the XLF ? (Buy the rumor / sell the news?)"

I wouldn’t short them with your money brother, replies Jeff Macke. I’d just walk away.

------------------

Yog from Florida

Yog writes, "What are the traders thoughts on Amgen after their earnings report?"

I think the whole space is ripe for consolidation, replies Karen Finerman.

To me, the stock is interesting around $51, adds Guy Adami.


______________________________________________________
Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to fastmoney@cnbc.com.

Trader disclosure: On Jan 28, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (BAC), (MSFT), (MS), (TM), (MCD); Seymour Owns (AAPL), (BAC), (EEM), (F), (FXI); Adami Owns (AGU), (C), (BTU), (GS), (INTC), (MSFT), (NUE); Finerman's Firm Owns (MSFT), (UNH); Finerman's Firm Owns (DNA) & (DNA) Call Spread; Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY), (COF), (USO)